How do evolutionarily conserved pathogen effectors maintain structural stability while engaging diverse host targets? In a new study published in Molecular Plant Microbe Interactions, researchers at ...

In the incredibly hot obesity drug space, with more than 700 clinical trials ongoing, Verdiva Bio and MitoRx leaders discuss how next-generation therapies are targeting lean muscle preservation, ...

BreezeBio, Inc., formerly known as GenEdit, today announced the close of $60 million in Series B financing to advance its first internal therapeutic programs toward the clinic and to continue ...

Chemify, the deep-tech pioneer of Chemputation ? a technological breakthrough that combines ML-based molecular discovery and automated, robotic synthesis ? today announced a collaboration with Sanacor ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

A modern, well-designed, WiFi 7-based network is also capable of separating traffic for fans, operations, media, and other ...

Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating Thykamine™ in a human ...

Discover expert-recommended feeding habits that improve your pet’s health, build trust, encourage training, and deepen the ...

How do evolutionarily conserved pathogen effectors maintain structural stability while engaging diverse host targets? In a new study published in ...

Dr. Bluestone is a world-renowned immunologist and biotech leader whose work has helped define modern understanding of immune regulation, tolerance, and translational immunology. His career spans ...

Another milestone has been reached on the mobile industry's journey to invent clever new things to do with connectivity.